Litcius/Paper detail

Hypersensitivity reactions after diagnostic nonvascular administration of iodine-based contrast media and gadolinium-based contrast agents and the role of the drug allergy specialist

Aart J. van der Molen, Francisco Vega, Annick van de Ven, Ilona A. Dekkers, José Julio Laguna

2024European Journal of Radiology12 citationsDOIOpen Access PDF

Abstract

The risk of hypersensitivity reactions (HSR) following nonvascular administration of contrast media (CM) for diagnostic studies is very low, likely due to minimal absorption into the systemic circulation. Most published individual cases of HSR after nonvascular CM administration are immediate reactions caused by ionic high-osmolar CM, few by nonionic low-osmolar CM, and none by gadolinium-based contrast agents. Measures to prevent recurrent HSR following nonvascular administration are similar to those recommended to prevent HSR after intravascular CM administration. Premedication as preventive measure has been abandoned, while switching to an alternative CM, preferably based on the results of an allergological analysis, is increasingly advocated. In selected scenarios, preventive measures may be minimized.

Topics & Concepts

MedicineGadoliniumContrast (vision)Gadolinium DTPADrugIodinated contrastIodineIodinated contrast mediaAllergyDrug allergyMagnetic resonance imagingRadiologyNuclear medicinePharmacologyComputed tomographyImmunologyArtificial intelligenceMaterials scienceComputer scienceMetallurgyDrug-Induced Adverse ReactionsContact Dermatitis and AllergiesMast cells and histamine
Hypersensitivity reactions after diagnostic nonvascular administration of iodine-based contrast media and gadolinium-based contrast agents and the role of the drug allergy specialist | Litcius